Better Money Decisions, LLC Gilead Sciences, Inc. Transaction History

Better Money Decisions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $17,316 - $19,503	300 New	300 $19,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $19,464 - $22,092	-300 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$63.47 - $69.35 $15,994 - $17,476	252 Added 525.0%	300 $21,000
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $2,880 - $3,286	48 New	48 $3,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Better Money Decisions, LLC, based on Form 13F filings with the SEC.

Stay updated on Better Money Decisions, LLC with notifications on news.